Whitehawk Therapeutics (WHWK) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q3 2025 value amounting to -$0.26.
- Whitehawk Therapeutics' EPS (Weighted Average and Diluted) rose 4347.83% to -$0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.13, marking a year-over-year increase of 10570.18%. This contributed to the annual value of -$2.36 for FY2024, which is 342.98% up from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' EPS (Weighted Average and Diluted) is -$0.26, which was up 4347.83% from -$0.76 recorded in Q2 2025.
- Whitehawk Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at $6.96 during Q4 2021, with a 5-year trough of -$9.17 in Q3 2021.
- In the last 5 years, Whitehawk Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.6 in 2021 and averaged -$0.53.
- As far as peak fluctuations go, Whitehawk Therapeutics' EPS (Weighted Average and Diluted) crashed by 1326165.81% in 2021, and later soared by 36911.76% in 2025.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' EPS (Weighted Average and Diluted) stood at $6.96 in 2021, then crashed by 106.9% to -$0.48 in 2022, then dropped by 25.0% to -$0.6 in 2023, then decreased by 12.67% to -$0.68 in 2024, then surged by 61.54% to -$0.26 in 2025.
- Its last three reported values are -$0.26 in Q3 2025, -$0.76 for Q2 2025, and $1.83 during Q1 2025.